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Abstract
Background: The low bacterial load in samples acquired from the lungs, have made studies on the airway
microbiome vulnerable to contamination from bacterial DNA introduced during sampling and laboratory
processing. We have examined the impact of laboratory contamination on samples collected from the lower
airways by protected (through a sterile catheter) bronchoscopy and explored various in silico approaches to dealing
with the contamination post-sequencing. Our analyses included quantitative PCR and targeted amplicon
sequencing of the bacterial 16S rRNA gene.
Results: The mean bacterial load varied by sample type for the 23 study subjects (oral wash>1st fraction of
protected bronchoalveolar lavage>protected specimen brush>2nd fraction of protected bronchoalveolar lavage;
p < 0.001). By comparison to a dilution series of know bacterial composition and load, an estimated 10–50% of the
bacterial community profiles for lower airway samples could be traced back to contaminating bacterial DNA
introduced from the laboratory. We determined the main source of laboratory contaminants to be the DNA
extraction kit (FastDNA Spin Kit). The removal of contaminants identified using tools within the Decontam R
package appeared to provide a balance between keeping and removing taxa found in both negative controls and
study samples.
Conclusions: The influence of laboratory contamination will vary across airway microbiome studies. By reporting
estimates of contaminant levels and taking use of contaminant identification tools (e.g. the Decontam R package)
based on statistical models that limit the subjectivity of the researcher, the accuracy of inter-study comparisons can
be improved.
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Background
The most common method used for studying the bacter-
ial communities of the lower respiratory tract is high
throughput amplicon sequencing of the bacterial 16S
ribosomal RNA (16S rRNA) marker gene [1]. Some
studies use sputum samples [2, 3], with inevitable ques-
tions regarding the degree to which the samples are repre-
sentative of the lower respiratory tract as opposed to
contamination from the upper respiratory tract. The
emerging gold standard for lower respiratory tract samples
is protected bronchoscopy (sampling via a sterile catheter)
[4]. However, even with protected bronchoscopy the sam-
ples are processed through extensive laboratory workflows
that include at minimum steps of bacterial DNA
extraction, PCR amplification of the marker gene, and
preparation for sequencing. Each step opens up the possi-
bility for the introduction of contaminating bacterial DNA
from the laboratory environment, with greatest impact on
samples with the lowest bacterial load [5].
Accurate analysis of the lower respiratory tract micro-
biome will require separate consideration of both of the
aforementioned contamination sources - that from the
upper respiratory tract introduced during sampling and
that introduced during laboratory processing steps. We
have previously shown that protected bronchoscopy of-
fers some protection from upper airway contamination
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[4]. In the current study, we address the issue of con-
tamination from the laboratory.
The impact of laboratory contamination is typically
evaluated through the inclusion of negative control sam-
ples (NCS) that are processed through all steps of DNA
extraction and library preparation for sequencing along-
side the study samples. The approach is not perfect as
one may expect to find taxa in the NCS that also belong
to the bacterial communities of the sampled site. Re-
searchers are thus faced with a difficult decision with
regards to what to do with the information acquired
from the NCS. Some groups have removed all taxa iden-
tified in NCS from their study samples [4, 6, 7]. Others
single out taxa they believe likely represent contaminants
[8]. Currently bioinformatic tools are being developed
that aim to wriggle out the authentic microbiota signal
using statistical models [9–11], but these have yet to be
tested on lower respiratory tract sequencing data (e.g.
Decontam [9]).
In the current paper we illustrate an effective workflow
for evaluating the quality of lower respiratory tract sam-
ples for accurate assessment of bacterial composition.
Objectives of the study were i) to determine the influ-
ence of contamination on lower respiratory tract sam-
ples as a function of bacterial load, ii) to determine the
main source of contamination in our laboratory setting
and iii) to explore common in silico approaches to deal-
ing with contamination.
Results
In order to establish the bacterial load in protected
airway samples collected using different sampling tech-
niques, we included oral washes (OW), two fractions of
protected bronchoalveolar lavage (PBAL1 and PBAL2)
and protected specimen brushes (PSB) from 23 partici-
pants of the MicroCOPD study [12]. The subject charac-
teristics are provided in Table 1.
Bacterial load varies with sample type
The bacterial load in the four sample types collected per
subject was measured by probe based quantitative PCR
(qPCR) targeting the bacterial 16S rRNA gene V1 V2
region. The bacterial load decreased in order OW >
PBAL1 > PSB > PBAL2 (p < 0.001, non-parametric trend
test) (Fig. 1). The mean number of bacteria (× 106/ mL
sample) was 34.2 (range 1.4 to 155.8) for OW (n = 23);
1.1 (range 1.7 × 10− 3 to 6.6) for PBAL1 (n = 23); 0.7
(range 4.3 × 10− 3 to 2.8) for PSB (n = 20) and 0.5 (range
19.9 × 10− 3 to 5.1) for PBAL2 (n = 23).
Bacterial load and impact of laboratory contamination
Salter and colleagues [5] have previously illustrated the
inverse relationship between the bacterial load in a sam-
ple and the influence of contamination on the bacterial
community readout. Once we had established that the
bacterial load varied with sampling technique (Fig. 1),
we questioned whether the differences in bacterial load
for each of the patient samples would also reflect differ-
ences in susceptibility to laboratory contamination.
Using the Salter approach [5], we estimated the degree
of contamination as a function of bacterial load (Fig. 2),
and translated this to an estimate of contamination in
the procedural samples (OW, PBAL, PSB). Using quanti-
tative PCR we determined that the initial Salmonella
sample had a concentration of 107 bacterial cells/mL. As
expected the oral wash samples having a high bacterial
load (mean of approximately 107 bacterial cells/mL), will
not be greatly impacted by contamination. Samples from
the lungs (PBAL, PSB) fell between dilution 2 and 3
(Fig. 2), with contamination representing 10–50% of
the bacterial community readout. The impact of vary-
ing number of PCR cycles was low (Fig. 2).
Monitoring procedural contamination
Having learned that contaminating bacterial DNA likely
represents a substantial proportion (10–50%) of the
sequencing output for the lower airway samples in our
study, we attempted to identify the main contamination
source. We performed ten simulated bronchoscopy
procedures (no patient) over two days to capture the
environmental contaminants that may have been intro-
duced during sampling.
All procedural control samples were sequenced to-
gether on the same sequencing run (Run A). Additional
control samples were sequenced on a second run (Run
B) and included samples of molecular grade water that
were processed through the DNA extraction protocol
without the introduction of PBS. Although sequenced
Table 1 Subject characteristics
Controls COPD Asthma
Subjects 9 10 4
Age 63.0 ± 6.7 68.2 ± 5.2 63.6 ± 3.1
Men 6 (66.7%) 8 (80.0%) 2 (50.0%)
Current-smokers 2 (22.2%) 1 (10.0%) 0
Former-smokers 5 (55.6%) 9 (90.0%) 3 (75.0%)
Non-smokers 2 (22.2%) 0 1 (25.0%)
Smoker pack years 11.8 ± 6.1 25.2 ± 8.1 12.1 ± 6.2
FEV1 (% predicted) 97.0 ± 13.7 72.6 ± 23.2 101.6 ± 9.3
Inhaled corticosteroids 0 2 (20.0%) 3 (75.0%)
LABA 0 3 (30.0%) 1 (25.0%)
LAMA 0 4 (40.0%) 0
COPD chronic obstructive pulmonary disease, FEV1 forced expiratory volume in
1 s, LABA long-acting beta-agonist, LAMA long-acting muscarinic antagonist. 1
smoker pack year = 20 cigarettes (one pack) smoked daily for 1 year. Age,
smoker pack years and FEV1 (% predicted) are presented as the
mean ± standard deviation
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on a separate sequencing run (Run B), the molecular
grade water samples would indicate whether the PBS
was the main source of contamination. A sample of mo-
lecular grade water that was not processed through the
DNA extraction protocol (PCR water) was also included
on both sequencing runs (Run A and B). This later
sample would reflect contamination introduced during
PCR and sequencing steps without interference from
contamination introduced during sampling and DNA
extraction steps.
The total number of sequences obtained from the pro-
cedural control samples (Run A) after quality filtering
Fig. 1 Measured bacterial load in procedural samples (OW, PBAL1, PSB and PBAL2). The mean bacterial load in OW samples was approximately
30 fold higher than PBAL1, 50 fold higher than PSB and, 70 fold higher than PBAL2. OW: oral wash (n = 23); PBAL1: first fraction of protected BAL
from right middle lobe (n = 23); PSB: protected specimen brush from right lower lobe (n = 20); PBAL2: second fraction of protected BAL from right
middle lobe (n = 23)
Fig. 2 Estimate of contaminant levels in ten-fold dilution series of Salmonella (SDS). The major operational taxonomic units (OTUs) observed in
the initial Salmonella sample (10^7 bacteria/mL) were assigned to f__Enterobacteriaceae;g__. Using the NCBI nucleotide BLAST tool we confirmed
that these OTUs (OTU821080, OTU813457 and OTU813217) matched to the genus Salmonella. With each successive dilution, the relative
abundance of f__Enterobacteriaceae;g__ decreased. By dilution 3 (45 PCR cycles), the percentage had reduced to 47.83%. For comparison, PCR
amplification of the 16S rRNA gene was performed at both 30 and 45 cycles for all SDS samples. The control is a sample of PCR water processed
through steps of PCR and sequencing alongside the SDS samples. Taxonomic rank is described using prefixes (f__: family, g__: genus)
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and chimera removal was 4.8 × 106. The mean number
of sequences and operational taxonomic units (OTUs)
obtained from the procedural controls were for phos-
phate buffered saline (n = 10): 64,745 sequences (123
OTUs); catheter rinse (n = 10): 98,379 sequences (131
OTUs); protected specimen brushes (n = 10): 106,853 se-
quences (132 OTUs); bronchoscope rinse (n = 10): 109,
765 sequences (134 OTUs); cryotube (n = 9): 115,633
sequences (138 OTUs). The number of sequences ob-
tained from the PCR water control sequenced on the
same run (Run A) was lower than for the procedural
control samples with only 43,433 sequences and 65
OTUs, suggesting that contamination was predomin-
antly introduced prior to PCR steps of library prepar-
ation. The procedural control samples (Run A) showed a
similar taxonomic distribution that was quite distinct
from that of the PCR water sample (Run A) (Fig. 3). This
indicated that contamination was either introduced with
the phosphate buffered saline used for collection of all
samples or during DNA extraction steps.
To differentiate between PBS and DNA extraction as
contamination sources, we compared the molecular
grade water samples (Run B) to the corresponding PCR
water sample sequenced on the same run. The molecular
grade water (n = 3) (Run B) contained a mean number of
124,941 sequences and 107 OTUs, whereas the PCR water
(Run B) contained 126,103 sequences and only 39 OTUs.
Importantly, the taxonomic profile of the molecular grade
water (Run B) resembled that of the procedural control
samples (Run A), whereas the PCR water did not, indicat-
ing that the main source of contamination was the DNA
extraction kit (Fig. 3).
Exploring in silico approaches to dealing with
contamination in LRT samples
We began our analyses by looking at how the top 20
OTUs present in NCS were distributed in the procedural
samples (OW, PBAL, PSB) in our 23 subjects (Fig. 4).
The NCS were dominated by an OTU that mapped to
the family Enterobacteriaceae. The Ralstonia OTU that
dominated the procedural controls (Fig. 3) was the
fourth most abundant OTU in the NCS with an average
relative abundance of just 5.45%. This likely reflects
differences in contamination introduced from different
Fig. 3 Distribution of operational taxonomic units (OTUs) in procedural controls and PCR water samples. An OTU belonging to the genera
Ralstonia dominated the procedural control samples with an average relative abundance of 51.81% in scope rinse (n = 10), 54.33% in catheter
rinse (n = 10), 55.36% in cryotube (n = 9), 52.82% in protected specimen brushes (n = 10) and 54.93% in phosphate buffered saline (n = 10). The
same Ralstonia OTU also dominated the molecular grade water samples (n = 3) at an average relative abundance of 29.42%. The PCR water
control sample was dominated by Rhizobium (38.11%), Anaerobacillus New Reference OTU 110 (20.69%) and Delftia (10.65%) in run A and
Anaerobacillus New Reference OTU 110 (32.93%), Anaerobacillus OTU 622288 (24.04%) and Delftia (10.68%) in run B. Taxonomic rank is described
using prefixes (o__: order, f__: family, g__: genus). Data unrarefied
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lots of the FastDNA Spin Kit [5]. An OTU assigned to
the Streptococcus genus was found in NCS at a relative
abundance of just 1.51%; the same OTU was a major
OTU in patient OW, PBAL and PSB samples. This is
most likely not a contaminant and may be an important
component of the bacterial lung microbiota. For a de-
tailed presentation of the Streptococcus OTUs found in
PSB and NCS samples, see Additional file 1: Figure S1
and Additional file 2: Figure S2.
Common in silico approaches to dealing with contam-
ination include i) leaving the samples intact (i.e. do
nothing), ii) removing all OTUs seen in NCS, and iii)
correction based on statistical models (i.e. the Decontam
R package). We next examined how the application of
each approach would impact the taxonomic profiles of
the procedural samples in our study (Fig. 5).
When leaving the procedural samples intact, the
Streptococcus genus dominated all sample types. With
the removal of OTUs seen in NCS, the relative abun-
dance of the Streptococcus genus was significantly re-
duced in all sample types (Fig. 5), as was predicted from
Fig. 4. With removal of OTUs identified as contaminants
using Decontam [9], the Streptococcus genus again
dominated the procedural samples. This approach thus
appeared to provide a good balance between removing
all OTUs found in the NCS and leaving intact OTUs
present in both NCS and procedural samples.
Comparison of the frequency-based distribution plots
for the top 4 OTUs observed in NCS and the Streptococ-
cus OTU (Fig. 6), visually illustrate how Decontam (here
frequency-based method) is able to differentiate between
a contaminant OTU and a non-contaminant OTU.
Decontam performance test on the Salmonella dilution
series (SDS)
In the Decontam introduction paper [9], the authors il-
lustrate how Decontam is able to diminish the contam-
inant signal from the serially diluted Salmonella datasets
published in the Salter paper [5]. As our study also in-
cluded a Salmonella dilution series (SDS), we were able
to test the Decontam package tools on sequencing data
generated in the context of our laboratory setting after
processing through our chosen bioinformatic pipeline.
The SDS in our study included seven samples of a
successively ten-fold diluted Salmonella monoculture
and a PBS negative control sample that went through
DNA extraction and sequencing steps alongside the SDS
(Fig. 7). As library preparation for sequencing of the
SDS was performed at both 30 and 45 PCR cycles and
the impact of varying number of PCR cycles was low
(Fig. 2), the sequencing output for both sample sets were
used as input in the Decontam analyses. We also in-
cluded a PCR water control sample that was sequenced
on the same sequencing run.
Fig. 4 Distribution of the 20 most abundant operational taxonomic units (OTUs) observed in negative control samples (NCS). The NCS were
dominated by OTU 759061 assigned to the family Enterobacteriaceae (20.93%), OTU 4389128 assigned to a genus within the class ML635J-21
(16.31%), OTU 437105 and New. Reference OTU 133 both assigned to the genus Ralstonia (8.30 and 5.45%, respectively). Taxonomic rank is
described using prefixes (c__: class, o__: order, f__: family, g__: genus). Data presented as the average relative abundance. Data unrarefied
Drengenes et al. BMC Microbiology          (2019) 19:187 Page 5 of 13
Using the isContaminant function in the Decontam R
package, we compared three methods for identification
of contaminant OTUs including i) the prevalence-based
method, ii) the frequency-based method and iii) the ei-
ther method. In the prevalence-based method, an OTU
is marked as a contaminant based on a comparison of
how often the OTU is observed in negative control sam-
ples compared to the samples under study. For testing
the approach on the SDS, the final two samples in the
SDS were assigned as negative control samples together
with PBS and PCR water samples (as conducted by
Decontam developers when testing the approach on the
Salter dataset [13]). Figure 8 shows the taxonomic pro-
file of the SDS samples after removal of contaminant
OTUs identified using the prevalence-based approach.
The impression was that many small OTUs were re-
moved. In the frequency-based approach, the labelling of
an OTU as a contaminant is based on the correlation
between the DNA concentration measurements made
for samples during steps of library preparation (in our
lab using the Qubit instrument) and the relative abun-
dance of the OTU across samples. Figure 9 shows the
taxonomic profile of the SDS samples after removal of
contaminant OTUs identified using the frequency-based
approach. The impression was that the frequency-based
approach removed fewer but more abundant OTUs
compared to the prevalence-based approach. In the final
approach tested in Decontam (“either”), all OTUs
marked as contaminants by either the prevalence or fre-
quency-based methods are removed (Fig. 10).
Of the three approaches tested in Decontam, the
“either” method was able to most effectively remove the
contaminant signal from the bacterial community pro-
files of the samples; even in the most diluted sample
over 50% of the sequences mapped to the Salmonella
genus. Of concern is however that the PBS sample also
consisted of over 50% Salmonella. Also present in the
PBS sample was oral/lung specific genera including Veil-
lonella, Streptococcus and Neisseria that are obvious
contaminants from the procedural samples sequenced
on the same run. The number of reads in the PBS sam-
ple after processing in Decontam was only 32. Therefore
we learn that although effective, removal of contaminant
OTUs identified in Decontam may also lead to the
magnification of another type of noise in the sequencing
data – particularly that from cross sample contamination
during library preparation or index misassignment dur-
ing MiSeq sequencing.
Discussion
In the current paper we illustrate an effective workflow
for evaluating the quality of lower airway samples for
amplicon-based analysis of bacterial composition. Our
results show that the low bacterial load in samples from
the lungs make them vulnerable to bacterial DNA con-
tamination, which in our study mainly originated from
Fig. 5 Taxonomic distribution in procedural samples when different approaches to dealing with contamination have been applied. When
negative control sample (NCS) operational taxonomic units (OTUs) are kept, the Streptococcus genus dominated the procedural samples with an
average relative abundance of 31.66% in oral wash (OW) (n = 23), 27.95% in protected bronchoalveolar lavage (PBAL) (n = 23) and 22.27% in
protected specimen brushes (PSB) (n = 23). With the removal of NCS OTUs, the Streptococcus genus no longer dominated the procedural samples
and was present at an average relative abundance of 4.80% in OW (n = 23), 6.12% in PBAL (n = 23) and 7.60% in PSB (n = 23). With the removal of
OTUs identified as contaminants in Decontam (method = “either”, threshold = 0.5), the Streptococcus genus again dominated the samples, with an
average relative abundance of 32.52% in OW (n = 23), 34.40% in PBAL (n = 23) and 35.08% in PSB (n = 23). Taxonomic rank is described using
prefixes (c__: class, o__: order, f__: family, g__: genus). Data unrarefied
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DNA extraction kits. Even with contaminants represent-
ing an estimated 10–50% of the sequencing output for
these samples, we demonstrate that most of the contam-
inating signal can be removed post sequencing using
recently developed bioinformatic approaches.
Through the processing and sequencing of a serially
diluted culture of Salmonella [5], we were able to define
the threshold bacterial load for which contamination
would begin to dominate the bacterial profile in our
samples. At an input of between 10^3 and 10^4 Salmon-
ella/mL, we observed that contaminants constituted
more than 50% of the bacterial profile of the sample.
The use of alternative protocols for sample processing
and sequencing can slide this defined threshold of
bacterial load up or down and should therefore be deter-
mined independently in separate studies. Biesbroek et al.
[14] for example show in their study how the choice of
DNA extraction kit will affect the DNA yield and in turn
the placement of samples above or below a defined
threshold of bacterial load for which contamination
becomes a problem. Despite differences in laboratory
protocols, our results are in agreement with Salter and
Fig. 6 Decontam frequency distribution plots distinguish contaminants from non-contaminants. A frequency distribution plot generated from
samples with varying DNA concentration indicates whether a particular sequence fits the Decontam contaminant (red line) or non-contaminant
(black stippled line) model. The first four plots represent the top four operational taxonomic units (OTUs) observed in negative control samples
(NCS): OTU 759061 is assigned to the family Enterobacteriaceae; OTU 4389128 is assigned to a genus within the class ML635J-21; OTU 437105 and
OTU New. Reference OTU 133 are both assigned to the genus Ralstonia. The final plot represents the Streptococcus OTU 1082539 that most likely
is not a contaminant, although present among the top 20 OTUs found in NCS. Its frequency distribution pattern more closely fits the Decontam
non-contaminant model in contrast to the others
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colleagues [5] who in their study also recommend an
input of more than 10^3–10^4 bacterial cells. The con-
cordance of our results may partially be explained by the
use of a DNA extraction kit from the same manufacturer
(FastDNA Spin Kit, MP Biomedicals).
Using the Salmonella dilution series as a reference we
were able to determine the degree of laboratory contam-
ination in the various sample types (OW, PBAL1,
PBAL2, PSB) collected from participants in the Micro-
COPD study. The average bacterial load in the samples
acquired from the lungs was highest for PBAL1 samples
(10^6 bacteria/mL) and approximately an order of mag-
nitude lower for PSB and PBAL2 samples. This could
mean that the first lavage fraction harvests a larger por-
tion of the resident microbiota, but also a dilution effect,
as lavage yield tends to increase in the second fraction.
We used a sterile inner catheter for lavage sampling, to
minimize contamination from BAL, something no other
study has done to our knowledge. It is however possible
that the first fraction of lavage (PBAL1) is more suscep-
tible to contamination from the upper airways during
sampling compared to PBAL2 and PSB samples [4].
Fig. 7 Taxonomic distribution in Salmonella dilution series (SDS). The taxonomic profile of the SDS samples (amplified using 45 PCR cycles) before
removal of OTUs identified as contaminants in Decontam. Taxonomic rank is described using prefixes (f__: family, g__: genus). Data unrarefied
Fig. 8 Taxonomic distribution in Salmonella dilution series (SDS) after removal of Decontam contaminants (prevalence-based). 109 out of 235
operational taxonomic units (OTUs) in the SDS dataset were identified as contaminants and removed (user defined threshold = 0.5). At the default
threshold, only 34 out of 235 OTUs in the dataset were identified as contaminants (figure not drawn). Taxonomic rank is described using prefixes
(f__: family, g__: genus). Data unrarefied
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Thus, the question remains as to whether PBAL1 with
its higher bacterial load is a more representative sample
compared to PBAL2 and PSB samples or if we are
simply swapping contamination sources (contaminating
bacterial DNA introduced from the upper airways
during sampling versus contaminating bacterial DNA
introduced during laboratory processing steps). The
optimal sample type may thus be a question of which
contamination source is easiest to identify and remove
post sequencing.
Through the sequencing of procedural control samples
and PCR negative control samples that were not proc-
essed through the DNA extraction protocol, we were
able to trace the main source of contamination back to
the DNA extraction kit. Our findings are in agreement
with several other studies [5, 15, 16]. The difference in
the microbiota readout for the procedural control
samples and the negative control samples are likely
explained by differences in lot number for the DNA
extraction kits. Salter and colleagues report differences
Fig. 9 Taxonomic distribution in Salmonella dilution series (SDS) after removal of Decontam contaminants (frequency-based). 58 out of 235
operational taxonomic units (OTUs) in the dataset were identified as contaminants and removed (user defined threshold = 0.5). At the default
threshold, only 9 out of 235 OTUs in the dataset were identified as contaminants (figure not drawn). Taxonomic rank is described using prefixes
(c__: class, o__: order, f__: family, g__: genus). Data unrarefied
Fig. 10 Taxonomic distribution in Salmonella dilution series (SDS) after removal of Decontam contaminants (approach either). 136 out of 235
OTUs in the dataset were identified as contaminants and removed (user defined threshold = 0.5). Taxonomic rank is described using prefixes (f__:
family, g__: genus). Data unrarefied
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in contaminant profiles for three replicates of SDS ex-
tracted using different lots of the FastDNA Spin Kit for soil;
similar to our results they also found that one SDS replicate
was dominated by unclassified Enterobacteriaceae.
Publications such as that by Salter and colleagues have
led to an increased awareness of the effects of con-
tamination on microbiome studies of low biomass
samples [5, 16]. Most studies now process negative control
samples that allow for monitoring of the contaminant sig-
nal introduced from the laboratory. However, the inclu-
sion of NCS only partly addresses the issue. In our study
for example, we recognized that a major Streptococcus
OTU found in procedural samples (OW, PBAL, PSB) was
also among the top 20 most abundant OTUs found in
NCS. A comparison of the relative abundance of the
Streptococcus OTU in procedural samples and NCS
indicated that the OTU was likely not a contaminant.
However, the question of where to draw the line with
regards to a set abundance threshold for which an OTU
should be identified as a contaminant or not is not always
as straightforward. The Decontam package in R has been
developed to identify contaminants using statistical
models [9]. The Decontam developers demonstrate the
accuracy of their approach on the Salmonella dilution
series datasets generated in the Salter publication. We
show in the context of our laboratory setting that Decon-
tam is efficient at removing the contaminant signal from
the SDS also in our study. Using Decontam we were also
able to confirm the identity of the Streptococcus OTU
found in both procedural samples and the NCS as a non-
contaminant.
We acknowledge that our study does not address all
issues related to bacterial load in microbiome sequen-
cing data. The serial diluted Salmonella monoculture
does not provide insight into the effects of bacterial load
on the relative abundance of bacteria in a more complex
microbiota sample. Biesbroek et al. [14] show in their
study examining the microbiota of a serially diluted
saliva sample, an increase in the relative abundance of
Proteobacteria and Firmicutes and a decrease in Bacter-
oidetes across the dilution series. Proteobacteria likely
reflect contaminants as has been suggested in several pa-
pers [14, 17], again illustrating the inverse relationship
between bacterial load and the influence of contamin-
ation as observed in our study. The observed increase in
relative abundance of Firmicutes and concurrent de-
crease in Bacteroidetes is however of concern, as these
phyla hold members often detected in studies of the lung
microbiome (e.g. Veillonella and Prevotella). The field
would benefit from studies addressing the potential ef-
fects of bacterial load on the measured relative abun-
dance of taxa in a more complex sample, particularly
those that are suspect core lung microbiota members.
Secondly, we did not quantify the amount of human
DNA in the procedural samples. The presence of human
DNA may affect the efficiency of the qPCR reaction
[16], and thereby also the accuracy of the direct compari-
son to the SDS. Studies evaluating the impact of contam-
ination might consider quantification of human DNA for
an even more accurate estimate of contamination.
Conclusions
Measured amounts of bacteria will vary in lower airway
samples collected with different bronchoscopic sampling
techniques (e.g. PBAL1, PBAL2, PSB in the current
study). These differences combined with the inverse re-
lationship between bacterial load and bacterial DNA
contamination will render some sampling modalities
dominated by contaminating taxa.
Differences in protocols for sampling, laboratory process-
ing and bioinformatics analysis across studies will require
investigators to evaluate the impact of contamination in the
context of their own laboratory setting. We encourage
investigators to report an estimate of the degree of contam-
ination in their datasets defined against a sample of known
bacterial load as exemplified in the current study. We
further suggest the use of contaminant identification tools
(e.g. Decontam) based on statistical models for the objective
removal of laboratory contaminants in lung microbiome
sequencing data. Such measures will enable more accurate
inter-study comparisons and may also resolve discrepancies
between studies that have likely impeded understanding the




Study subjects (n = 23) were chosen from the Bergen
COPD Microbiome Study (short name “MicroCOPD”)
[12], to give an equal representation of healthy (n = 9) and
diseased (asthma (n = 4), COPD (n = 10)) states. Details on
data collection and the bronchoscopy procedures have
been previously published [4, 12]. Briefly, adult subjects
recruited from Western Norway with and without ob-
structive lung disease, underwent voluntary bronchosco-
pies between 2013 and 2015. All subjects were examined
in the stable state, not having received antibiotics at least
2 weeks prior to the procedure. All bronchoscopies were
performed by experienced chest physicians at the out-
patient clinic at the Department of Thoracic Medicine,
Haukeland University Hospital. The regional ethical
committee (REK-Nord, case # 2011/1307) approved the
study, and all patients gave written informed consent.
Sample types acquired per patient included the first
and second fraction of 2 × 50mL bronchoalveolar lavage
(PBAL1 and PBAL2) sampled through a sterile inner
catheter (Plastimed Combicath, Le Plessis Bouchard,
France) of the bronchoscope while the scope itself was
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wedged in the right middle lobe, and three protected
specimen brushes subsequently sampled from the right
lower lobe (rPSB), an oral wash (OW), and a negative
control sample (NCS). Additional procedural control
samples were collected after ten simulated bronchoscopy
procedures (no patient) carried out over two days;
samples included a bronchoscope rinse (BR), a catheter
rinse (CR), a protected specimen brush (PSB), a sample
of phosphate buffered saline (PBS) transferred to a cryo-
tube (CT) and a sample of PBS used for collection of all
samples. The PBS used for sample collection was sterilized
by sterile filtration (0.22 μm) and autoclaving at 121 °C for
15min. To study the relationship between bacterial load
and the influence of contaminating bacterial DNA in our
laboratory setting [5], we included a ten-fold dilution
series of Salmonella enterica serovar Typhimurium
(ATCC 14028) (ATCC, Manassas, VA, USA) (SDS).
Bacterial DNA extraction using enzymatic and mechanical
lysis steps
Samples were treated with lytic enzymes mutanolysin,
lysozyme and lysostaphin (all from Sigma-Aldrich, St.
Louis, MO, USA) and subsequently processed through
the FastDNA Spin Kit (MP Biomedicals, LLC, Solon,
OH, USA) following the manufacturer’s instructions.
Procedural samples were processed using different lots
of the DNA extraction kit (#79113, #84562, #57212,
#62903). The procedural controls and the SDS were
processed using a kit of same lot number (#93678). The
sample volume used as input varied with sample type
(for procedural samples: 450 μl for PSB and NCS and
1800 μl for OW, PBAL1, PBAL2; for procedural control
samples: 450 μl for PBS and CT, 550 μl for PSB and
1800 μl for BR and CR; for samples in the SDS: 500 μl).
DNA was eluted in a total volume of 100 μl.
Quantification of bacterial load by quantitative PCR
(qPCR)
The bacterial load in the samples was determined by
probe-based qPCR targeting the bacterial 16S rRNA
gene (region V1 V2) using forward primer 5′-AGAGTT
TGATCCTGGCTCAG-3′, reverse primer 5′-CTGCTG
CCTYCCGTA-3′ and probe 5′-6-FAM-TAACACATG-
CAAGTCGA-BHQ-1-3′ (locked nucleic acid bases are
underlined; 6-FAM: 6-carboxyfluorescein; BHQ-1: Black
Hole Quencher-1) [7, 18–20]. PCR reactions were car-
ried out using the following cycling conditions: an initial
cycle at 95 °C for 5 min followed by 45 cycles of 95 °C for
5 s, 60 °C for 20 s and 72 °C for 10 s and a final extension
cycle of 72 °C for 2min. A standard curve was constructed
from genomic DNA from E. coli strain JM109 (Zymo
Research, Irvine, CA, USA).
MiSeq sequencing of the bacterial 16S rRNA gene
The bacterial composition in the samples was deter-
mined by paired-end sequencing of the 16S rRNA gene
(region V3 V4) following instructions provided in the
Illumina 16S Metagenomic Sequencing Library Prepar-
ation guide (Part no. 15044223 Rev. B). PCR cycling con-
ditions were modified from the commercial protocol and
consisted of an initial cycle at 95 °C for 3min followed by
45 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s and
a final extension cycle at 72 °C for 5min.
Bioinformatic sequence processing steps
Bioinformatic sequence processing steps were performed
using tools provided within the Quantitative Insights
into Microbial Ecology (QIIME) bioinformatic package,
version 1.9.1. In short, raw sequences were retrieved
from the MiSeq sequencer in the form of demultiplexed
forward and reverse fastq files (paired end reads). Primer
sequences were trimmed off and forward and reverse
reads joined. Chimera sequences identified using the
VSEARCH program [21] were subsequently removed.
Remaining sequences were grouped into open-reference
operational taxonomic units (OTUs) using UCLUST
[22] and the GreenGenes reference database (v.13.8)
[23]. Small OTUs, defined as those containing less than
0.005% of the total sequence count in the dataset were
then filtered out [24]. Taxonomy was assigned to OTUs
using the naïve bayesian RDP Classifier [25] together
with the GreenGenes reference database (v.13.8) [23].
The resulting OTU table displaying the sequence count
in each OTU for each sample was the starting point for
all subsequent analyses. The QIIME commands used for
generating the working OTU table are provided in the
Additional file 3: Supplementary Methods.
In silico contaminant identification and removal
Two approaches to contaminant identification and
subsequent removal were tested. In the first approach
contaminant OTUs were identified through their
presence in NCS. NCS OTUs were filtered out from the
procedural samples (OW, PSB, PBAL) collected under
the same procedure using QIIME commands (illustrated
in the supplementary methods). In the second approach,
contaminant OTUs were identified based on statistical
models using the Decontam package [9] in R. Contamin-
ant OTUs identified using the Decontam isContaminant
function (method = either, user defined threshold = 0.5)
were filtered out of the main OTU working table using
QIIME commands.
For greater details on study design, sample collection,
preparation of Salmonella samples, DNA extraction,
qPCR, 16S rRNA gene sequencing and bioinformatics,
please see the Additional file 3: Supplementary Methods.
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Additional files
Additional file 1: Figure S1. Distribution of Streptococcus OTUs in
Protected Specimen Brush (PSB) samples (n=23). (PDF 8 kb)
Additional file 2: Figure S2. Distribution of Streptococcus OTUs in
Negative Control Samples (NCS) (n=23). (PDF 8 kb)
Additional file 3: Supplementary Methods. This file provides a detailed
description of protocols for sample collection, preparation of Salmonella
samples, DNA extraction, qPCR, 16S rRNA gene sequencing and
bioinformatics. (DOCX 240 kb)
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